Insurers Are Using Cancer Patients as Leverage

Major health insurers are threatening to drop renowned cancer centers from their networks during contract negotiations, Memorial Sloan Kettering Cancer Center's president and CEO Selwyn M. Vickers and chairman Scott M. Stuart wrote in a story published by WSJ. Memorial Sloan Kettering Cancer Center reported that both Anthem Blue Cross Blue Shield and UnitedHealthcare prepared to terminate network agreements while patients underwent active cancer treatment. FTI Consulting found that 45% of 133 provider-payer disputes in 2024 failed to reach timely agreements. The disruptions have affected tens of thousands of patients. Research published in the Journal of the National Cancer Institute found that care disruptions lead to more advanced-stage diagnoses and worse outcomes. Similar contract disputes involved Mayo Clinic, Johns Hopkins University and University of North Carolina Health. New York lawmakers introduced legislation this year requiring insurers to maintain coverage for cancer patients during negotiations and until treatment concludes. Memorial Sloan Kettering's leadership described the practice as using patients as bargaining chips despite record insurer profits.

Read more of this story at Slashdot.